Among the AS events associated with survival differences, we identified an exon skipping event in the cell adhesion molecule CEACAM1 in 114 TCGA breast cancer patients (Figs. 4B and 5, A to C) that was previously described in another breast cancer cohort (35). This evidence concerns the gene CEACAM1 and breast carcinoma.